Bottom line: Abbott confirms two separate cyber incidents in critical diagnostic systems with indications of data exfiltration and extortion attempts.
Abbott Laboratories confirms unauthorized access to internal legacy systems of the Exact Sciences division for cancer diagnostics and simultaneously investigates a further incident with claims of data acquisition through the LabCentral portal. The corporation is examining possible extortion attempts by attackers.
Abbott Laboratories is investigating two separate security incidents following confirmed unauthorized access to internal legacy systems of Exact Sciences, a business unit in the cancer diagnostics field. In parallel, the company is examining claims that attackers also breached the LabCentral portal and were able to exfiltrate corporate data.
For a CISO, this creates several immediate areas for action: on one hand, forensic analysis of both incidents to determine the access window, affected systems, and the type of compromised data. On the other hand, communication with regulatory authorities and potentially patients must take place if sensitive health data is involved.
In an operational context, the risk constellation of legacy systems is once again evident, which often carry higher exploitation risks. The parallel occurrence of two incidents suggests either possible systemic vulnerabilities or coordinated attack campaigns. Extortion attempts are typically linked to data exfiltration scenarios, which is why a data loss prevention assessment and threat intelligence research into the actors involved are essential.
Source: www.bleepingcomputer.com · Published July 17, 2026
Lumi AI News — AI-assisted curation pursuant to Art. 50 EU AI Act. Paraphrasing and classification by Lumi News Pipeline v1.7.3.